$1.70 solid News... CVM https://www.businesswire.com/news/home/20240508140076/en/CEL-SCI-Receives-FDA-Go-Ahead-for-Its-Confirmatory-Study-of-Multikine-in-the-Treatment-of-Head-Neck-Cancer